| http://www.w3.org/ns/prov#value | - The European Union???s Grand Court judgement in 'Br??stle v Greenpeace' (October 2011), which ruled that stem cells from human embryos cannot be patented, means that the commercial value of IP in such interventions will migrate, for example, to enabling technologies such as processing equipment and devices.
|
